ARTICLE | Company News
Quest Group, Vitae deal
May 21, 2007 7:00 AM UTC
Vitae granted QSTG exclusive rights to three undisclosed pharmaceutical programs that include retinoic acid receptor and rexinoid receptor agonists and antagonists, as well as related molecules. QSTG...